StemGen, Inc. reported earnings results for the first quarter ended September 30, 2021. For the first quarter, the company reported net loss was USD 0.136027 million compared to USD 0.086674 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 USD | -.--% | -.--% | -.--% |
2022 | D3eSports Announces Supporting Partnership With United States Esports Federation | CI |
2022 | StemGen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 4.57M | |
+10.58% | 66.4B | |
-3.87% | 13.56B | |
+29.65% | 8.56B | |
+6.90% | 6.71B | |
-11.22% | 5.08B | |
+21.53% | 4.83B | |
-9.30% | 4.76B | |
-2.58% | 3.42B | |
+5.83% | 3.09B |
- Stock Market
- Equities
- SGNI Stock
- News StemGen, Inc.
- StemGen, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2021